SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Annual Wellness Visit, Initial — Dwight D. Eisenhower

PatientDwight D. Eisenhower
Date of birth1960-10-14
IdentifiersMRN HR-ET015-SYN; SSN (made up) 000-15-2673
Document date2026-10-19
AuthorRussell Okonkwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Initial annual wellness visit; no new complaints. [S]

History of Present Illness

Mr. Eisenhower comes for his first annual wellness visit, three weeks after his one-year coronary review, at which ticagrelor was stopped and he continued aspirin alone. He completed the health risk assessment before the visit. He has had no chest pain, breathlessness, palpitations, or further nosebleeds, and has not needed nitroglycerin. He works full time, travels often, walks most days, and plays golf twice a week. He takes his medicines from a weekly organizer and has added no over-the-counter medicines or supplements. He has had no falls. [S]

ElementDetail
VisitInitial annual wellness visit
Cardiac symptomsNone; no nitroglycerin use
Safety eventsNo falls; no further nosebleeds
MedicinesAdherent with a weekly organizer; no new over-the-counter medicines or supplements
Active conditionsCoronary artery disease after myocardial infarction, hyperlipidemia, and hypertension, all controlled
Functional statusIndependent in all activities and instrumental activities of daily living; working full time

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthVery good, and better than a year ago
PsychosocialMarried; strong family and work supports; work stress high but manageable; sleeps about seven hours
BehavioralFormer heavy cigarette smoker, quit about seven years ago, no relapse; one or two drinks a week; walks most days and plays golf twice a week; Mediterranean-style diet
Activities of daily livingIndependent in bathing, dressing, eating, toileting, and transfers
Instrumental activities of daily livingManages his own medicines, finances, and travel
Home safetySmoke detectors working; seat belt always; firearms not kept at home
Hearing and visionNo hearing concerns; reading glasses; last eye examination more than two years ago
BladderNo urinary symptoms
MemoryNo concerns from him or his family

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight stable; good energy; no fever
EyesNegativeNo change in vision with reading glasses
Ears, nose, mouth, and throatNegativeNo hearing loss or further nosebleeds
CardiovascularNegativeNo chest pain, palpitations, orthopnea, or ankle swelling
RespiratoryNegativeNo cough or breathlessness
GastrointestinalNegativeNo black stools or reflux
GenitourinaryNegativeNo hesitancy, nocturia beyond once, or hematuria
MusculoskeletalNegativeNo joint pain or falls
IntegumentaryNegativeNo new or changing skin lesions
NeurologicalNegativeNo weakness, numbness, speech change, or memory change
PsychiatricNegativeMood good; PHQ-2 score 0
HematologicNegativeLess bruising since ticagrelor stopped

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Aspirin 81 mg delayed-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2025-09-24activeS
Ticagrelor 90 mg oral tablet, one tablet by mouth twice dailyOne tablet by mouth twice dailyOral route2025-09-24 to 2026-09-28completedS
Atorvastatin 80 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2025-09-24activeS
Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2025-09-25activeS
Lisinopril 5 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2025-09-26 to 2026-01-12completedS
Lisinopril 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-01-12activeS
Ezetimibe 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-01-12activeS
Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tabletOne tablet under the tongue every 5 minutes as needed for chest pain, up to 3 dosesSublingual route2025-09-24activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-19Body height178cmS
2026-10-19Body weight77.2kgS
2026-10-19Body mass index (BMI) [Ratio]24.4kg/m2S
2026-10-19Systolic blood pressure126mm[Hg]S
2026-10-19Diastolic blood pressure76mm[Hg]S
2026-10-19Heart rate60/minS
2026-10-19Respiratory rate14/minS
2026-10-19Body temperature36.6CelS
2026-10-19Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-19Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-10-19Total score [Mini-Cog]5{score}S
2026-10-19Total score [AUDIT-C]1{score}S

Physical Exam

Vital signs recorded on 2026-10-19; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell-appearing; weight 77.2 kg, stable
EyesPupils equal and reactive; near vision 20/25 with reading glasses
EarsCanals clear; whispered-voice test passed on both sides
NeckNo carotid bruits; jugular venous pressure not raised
CardiovascularRegular rhythm; no murmur or gallop; pedal pulses present; no edema
RespiratoryClear to auscultation bilaterally
AbdomenSoft and non-tender; no pulsatile mass or aortic bruit
MusculoskeletalTimed Up and Go 8 seconds with a steady gait
NeurologicalOriented; Mini-Cog 5 of 5 (recall 3 of 3, clock normal)
PsychiatricEuthymic, direct, and engaged
SkinSun damage on the scalp and forearms; no suspicious lesions

Problems

ProblemClinical statusVerificationCodeProvenance
Anterior ST-elevation myocardial infarction about four months before intake, treated with a drug-eluting stent to the left anterior descending artery; synthetic modern episode linked to the documented 1955 anterolateral infarctionactiveconfirmed I25.2S — Synthetic modern diagnosis; the 1955 infarction remains D in the history.
Coronary artery disease, single-vessel, after stenting; no anginaactiveconfirmed I25.10S — Synthetic diagnosis supporting secondary prevention.
Hyperlipidemia, on high-intensity statinactiveconfirmed E78.5S — Synthetic diagnosis; no cholesterol value from his lifetime is used.
Essential hypertensionactiveconfirmed I10S — Synthetic diagnosis; no blood pressure from his lifetime is used.
Former heavy cigarette smoker, quit about seven years before intakeactiveconfirmed Z87.891S — Synthetic coded history echoing the documented heavy smoking and quitting around 1949.
Anterior epistaxis, right side, on dual antiplatelet therapy; controlled with silver nitrate cauteryresolvedconfirmed R04.0S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Influenza vaccine, 2026-2027Completed todayHigh-dose vaccine given today
COVID-19 vaccine, 2026-2027DueRecommended with coronary disease; he plans to get it at his pharmacy
Pneumococcal vaccineUp to datePCV20 given in January; no further doses needed
RSV vaccineUp to dateSingle dose given at the one-year review three weeks ago
Recombinant zoster vaccineUp to dateTwo-dose series completed about three and a half years ago
Tetanus boosterUp to dateTdap about seven years ago; next due in about three years
Abdominal aortic aneurysm screeningOrderedOne-time ultrasound for a man aged 65 to 75 who has ever smoked
Lung cancer screeningOrderedAge 66, well over 20 pack-years, quit about seven years ago. After shared decision-making about benefits, false positives, and radiation, he chose yearly low-dose CT; first scan ordered
Colorectal cancer screeningUp to dateNormal colonoscopy five years ago; next due in five years
Prostate cancer screeningDeclinedShared decision-making about the small benefit and the risks of overdiagnosis; he chose not to have PSA testing
Hepatitis C screeningUp to dateOne-time screen negative in the past
Cholesterol and diabetes screeningUp to dateLDL cholesterol 49 mg/dL three weeks ago; HbA1c 5.6% in January, due again in January
Depression screeningCompleted todayPHQ-2 score 0
Unhealthy alcohol use screeningCompleted todayAUDIT-C score 1
Cognitive assessmentCompleted todayMini-Cog 5 of 5
Falls and functional assessmentCompleted todayNo falls; Timed Up and Go 8 seconds
Tobacco useCompleted todayAbstinent; relapse-prevention advice given
Eye examinationDueMore than two years since his last examination; he will book with his optometrist

Immunizations given today: High-dose influenza vaccine, 2026-2027 season [S]

Guideline basis: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); Medicare Wellness Visits (Medicare Learning Network) (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026)

Follow-up: Abdominal aortic ultrasound and low-dose chest CT ordered. Coronary review with laboratory tests in about six months. Subsequent annual wellness visit in one year. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He has named a health care agent and completed a written health care directive; a copy is now in the chart. He wants full treatment, including coronary procedures and intensive care, for any condition from which he could return to an active life. He would not want prolonged life support if he were unlikely to recover the ability to think and communicate. He will review these wishes with his agent. [S]